In vitro reconstitution of indolmycin biosynthesis reveals the molecular basis of oxazolinone assembly

Yi-Ling Du,Lona M. Alkhalaf,Katherine S. Ryan
DOI: https://doi.org/10.1073/pnas.1419964112
IF: 11.1
2015-02-17
Proceedings of the National Academy of Sciences
Abstract:Significance Resistance to current antibiotics is rising worldwide, and replacement molecules are urgently needed. The tryptophanyl–tRNA synthetase inhibitor indolmycin, containing a unique oxazolinone core, was first isolated in 1960, but the molecular basis for its construction is still unknown. Here we report the complete pathway to indolmycin, using a combination of genetic and biochemical approaches. Our work reveals how the oxazolinone core is assembled by the dual action of the ATP-dependent enzyme Ind3, and Ind6, an unusual gatekeeper protein. Our work sets the stage for generating improved microbial production systems for indolmycin and for development of indolmycin-like antibiotics.
What problem does this paper attempt to address?